Cargando…

Therapeutic effects of axitinib, an anti-angiogenic tyrosine kinase inhibitor, on interstitial cystitis

To investigate the therapeutic effects of axitinib, a tyrosine kinase inhibitor, in an interstitial cystitis (IC) rat model. IC patients with or without Hunner lesion and non-IC controls were enrolled (n = 5/group). Bladder tissues were stained with vascular endothelial growth factor (VEGF), VEGF re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Jung Hyun, Ryu, Chae-Min, Yu, Hwan Yeul, Park, Yang Soon, Shin, Dong-Myung, Choo, Myung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205792/ https://www.ncbi.nlm.nih.gov/pubmed/37221266 http://dx.doi.org/10.1038/s41598-023-35178-5

Ejemplares similares

Synergistic Effects of N-Acetylcysteine and Mesenchymal Stem Cell in a Lipopolysaccharide-Induced Interstitial Cystitis Rat Model
por: Shin, Jung Hyun, et al.
Publicado: (2019)

Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion
por: Choi, Daeheon, et al.
Publicado: (2018)

Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I Study
por: Shin, Jung Hyun, et al.
Publicado: (2022)

Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndrome
por: Ryu, Chae-Min, et al.
Publicado: (2018)

N-acetylcysteine prevents bladder tissue fibrosis in a lipopolysaccharide-induced cystitis rat model
por: Ryu, Chae-Min, et al.
Publicado: (2019)

Elimination of Hunner's Ulcers by Fulguration in Patients With Interstitial Cystitis: Is It Effective and Long Lasting?
por: Ryu, Jeman, et al.
Publicado: (2013)

Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment
por: Kim, Aram, et al.
Publicado: (2017)

Current and Future Directions of Stem Cell Therapy for Bladder Dysfunction
por: Shin, Jung Hyun, et al.
Publicado: (2019)

Axitinib Induces and Aggravates Hypertension Regardless of Prior Treatment With Tyrosine Kinase Inhibitors
por: Kadowaki, Hiroshi, et al.
Publicado: (2021)

The Therapeutic Effect of Human Embryonic Stem Cell-Derived Multipotent Mesenchymal Stem Cells on Chemical-Induced Cystitis in Rats
por: Lee, Sang Wook, et al.
Publicado: (2018)

Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder
por: Kim, Aram, et al.
Publicado: (2016)

Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
por: Halbach, Sebastian, et al.
Publicado: (2016)

Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma
por: Hudson, C D, et al.
Publicado: (2014)

Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome
por: Wang, Guang, et al.
Publicado: (2022)

Pretreatment Features to Influence Effectiveness of Intravesical Hyaluronic Acid Instillation in Refractory Interstitial Cystitis/Painful Bladder Syndrome
por: Kim, Aram, et al.
Publicado: (2014)

Angiogenic factors, bladder neuroplasticity and interstitial cystitis—new pathobiological insights
por: Saban, Ricardo
Publicado: (2015)

Interleukin-33 as a Potential Therapeutic Target for Interstitial Cystitis: New Perspectives on Mast Cell Regulation
por: Choo, Min Soo
Publicado: (2015)

Therapeutic Efficacy of Human Embryonic Stem Cell-Derived Multipotent Stem/Stromal Cells in Diabetic Detrusor Underactivity: A Preclinical Study
por: Shin, Jung Hyun, et al.
Publicado: (2020)

The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib
por: G. Lindström, H. Jonathan, et al.
Publicado: (2020)

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
por: Gotink, Kristy J., et al.
Publicado: (2009)

Increased Expression of Neuregulin 1 and erbB2 Tyrosine Kinase in the Bladder of Rats With Cyclophosphamide-Induced Interstitial Cystitis
por: Song, Ki Hak, et al.
Publicado: (2015)

Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2020)

Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma
por: Murphy, Danielle A, et al.
Publicado: (2020)

Co-Morbidities of Interstitial Cystitis
por: Chelimsky, Gisela, et al.
Publicado: (2012)

Interstitial cystitis intravesical therapy
por: Ha, Tanya, et al.
Publicado: (2017)

Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
por: Park, Chang-Shin, et al.
Publicado: (2011)

Development of the Interstitial Cystitis Self-Help and Medical Resources Scale (ICSR) for Women with Interstitial Cystitis
por: Chen, Hui-Chun, et al.
Publicado: (2022)

TGF-β inhibitor treatment of H₂O₂-induced cystitis models provides biochemical mechanism for elucidating interstitial cystitis/painful bladder syndrome patients
por: Taga, Hideto, et al.
Publicado: (2023)

Small‐sized mesenchymal stem cells with high glutathione dynamics show improved therapeutic potency in graft‐versus‐host disease
por: Lim, Jisun, et al.
Publicado: (2021)

Induction of detrusor underactivity by extensive vascular endothelial damages of iliac arteries in a rat model and its pathophysiology in the genetic levels
por: Kim, Myong, et al.
Publicado: (2019)

A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
por: Yu, Hwan Yeul, et al.
Publicado: (2021)

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
por: Fleuren, Emmy D. G., et al.
Publicado: (2023)

Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer
por: Dervisis, Nikolaos, et al.
Publicado: (2016)

Current guidelines in the management of interstitial cystitis
por: Colaco, Marc, et al.
Publicado: (2015)

How does interstitial cystitis begin?
por: Parsons, C. Lowell
Publicado: (2015)

An update on treatment options for interstitial cystitis
por: Garzon, Simone, et al.
Publicado: (2020)

Non-Hunner's Interstitial Cystitis Is Different from Hunner's Interstitial Cystitis and May Be Curable by Uterosacral Ligament Repair
por: Goeschen, Klaus, et al.
Publicado: (2022)

The Use of Urine Proteomic and Metabonomic Patterns for the Diagnosis of Interstitial Cystitis and Bacterial Cystitis
por: Van, Que N., et al.
Publicado: (2004)

The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis
por: Zhao, Jiang, et al.
Publicado: (2016)

The NLRP3 Inflammasome Inhibitor Dapansutrile Attenuates Cyclophosphamide-Induced Interstitial Cystitis
por: Kiran, Sonia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i35i5knbkvq6moqr7dmdenrsmb